Vivani Medical Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -39.4% | +41.1% | +121.6% | -28.0% | +93.1% | -68.6% | +95.4% | +17.8% | -21.3% | -36.2% | +13.7% | -63.2% | +5.3% | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +26.5% | -65.9% | +0.0% | -11.2% | +86.0% | -64.1% | +25.1% | +113.4% | -10.3% | -54.3% | +27.6% | -61.0% | -65.9% | -12.1% | -81.7% | – | – | – | – | – | – | – | – | +2,272.7% | -57.9% | -1.8% | -25.9% | -11.3% | +38.0% | +1.0% | +1.0% | +12.0% | -20.5% | +14.6% | – | – | +9.5% | +13.0% | – | – | |
| – | – | – | – | -45.1% | +104.8% | -75.3% | +247.7% | -56.9% | -64.1% | +139.2% | -12.1% | -69.1% | +245.4% | -129.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +31.0% | -11.2% | +5.5% | -6.3% | +24.4% | +8.9% | -2.1% | +10.3% | -8.8% | -10.5% | +57.4% | -1.7% | +50.8% | -23.7% | -80.7% | -62.9% | +597.8% | +23.6% | +14.4% | +4.2% | +3.7% | -9.9% | +19.6% | +20.5% | +14.7% | -10.7% | -2.3% | +14.9% | +6.0% | -20.9% | -5.7% | +19.6% | +2.2% | -1.9% | +12.9% | -5.0% | +2.5% | -8.0% | +4.6% | – | |
| – | -6.1% | +12.1% | +5.8% | -12.9% | +9.3% | +17.5% | -18.9% | -11.4% | +6.5% | -1.4% | -7.9% | -3.5% | +7.6% | -13.7% | -25.0% | -29.9% | +26.6% | -57.7% | -2.5% | +11.2% | -7.1% | +114.3% | -28.0% | +79.3% | +4.9% | +59.1% | +18.6% | -13.9% | -44.2% | +65.7% | -13.3% | -2.9% | +2.4% | +8.5% | +15.5% | -18.4% | -1.2% | +11.3% | -0.4% | – | |
| – | +10.3% | -4.5% | +7.3% | -7.8% | +18.0% | +16.1% | -10.1% | -0.6% | -5.8% | -8.8% | +2.3% | -2.4% | +9.2% | -12.1% | -69.7% | -28.7% | -21.5% | +136.5% | +11.2% | +5.4% | +1.8% | +10.1% | +4.6% | +33.2% | +43.1% | -15.3% | +6.1% | +2.0% | -14.3% | +1.8% | -8.8% | +11.1% | +1.0% | +2.9% | +13.8% | -9.9% | +1.3% | -1.8% | +2.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.9% | +42,818.8% | -92.9% | -41.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -611.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.0% | -46.2% | +314.3% | +127.6% | -63.6% | -33.3% | +68.8% | -11.1% | -20.8% | +257.9% | -98.5% | +3,400.0% | +637.1% | -93.0% | -11.1% | -106.3% | – | – | – | -1,000.0% | – | – | -5.9% | -43,018.8% | – | – | – | – | +155.9% | -80.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -611.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -492.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.